Navigation Links
Allergen, Food, Spinach

ProductsAllergen, Food, Spinach
Company ARUP Laboratories
Item Allergen, Food, Spinach
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Allergen, Drugs, Amoxicillin
2. Allergen, Drugs, Ampicillin
3. Allergen, Drugs, Penicillin G (major)
4. Allergen, Drugs, Penicillin V (minor)
5. Allergen, Epidermals & Animal Proteins,Budgerigar Droppings (Parakeet)
6. Allergen, Epidermals & Animal Proteins, Aust Parrot Droppings
7. Allergen, Epidermals & Animal Proteins,Chicken Feathers
8. Allergen, Epidermals & Animal Proteins, Cat Epithelium & Dander
9. Allergen, Epidermals & Animal Proteins, Cow Hair & Dander
10. Allergen, Epidermals & Animal Proteins, Dog Dander
11. Allergen, Epidermals & Animal Proteins, Dog Epithelium
Breaking Medicine Technology:Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Abbott Announces TCT 2009 Activities 57402 1Abbott Announces TCT 2009 Activities 57402 2Abbott Announces TCT 2009 Activities 57402 3Abbott Announces TCT 2009 Activities 57402 4Abbott Announces TCT 2009 Activities 57402 5PharmAbcine Closes USD 246 Million Series A Financing 14102 1PharmAbcine Closes USD 246 Million Series A Financing 14102 2PharmAbcine Closes USD 246 Million Series A Financing 14102 3PharmAbcine Closes USD 246 Million Series A Financing 14102 4The Simmons Firm to Host Midwest Asbestos Litigation Conference 57399 1The Simmons Firm to Host Midwest Asbestos Litigation Conference 57399 2